§ Funding Round
Series A funding round for Ottimo Pharma raising $140M in December 2024
Series A funding round for Ottimo Pharma raising $140M in December 2024
| Investor | Firm Type | Partner |
|---|---|---|
Arix Bioscience | — | — |
OrbiMedLEAD | Organization | — |
Avoro Capital AdvisorsLEAD | — | — |
Samsara BioCapitalLEAD | — | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$140M
Top Valuation
-
Ottimo Pharma raised $140M in a Series A round.
The round was announced on 12/01/24.
The round was led by OrbiMed, Avoro Capital Advisors, Samsara BioCapital.
